ORIC
Price
$10.27
Change
+$0.01 (+0.10%)
Updated
Nov 13 closing price
131 days until earnings call
PRTA
Price
$17.23
Change
-$0.13 (-0.75%)
Updated
Nov 13 closing price
91 days until earnings call
Ad is loading...

ORIC vs PRTA

Header iconORIC vs PRTA Comparison
Open Charts ORIC vs PRTABanner chart's image
Oric Pharmaceuticals
Price$10.27
Change+$0.01 (+0.10%)
Volume$534.24K
CapitalizationN/A
Prothena
Price$17.23
Change-$0.13 (-0.75%)
Volume$387.32K
CapitalizationN/A
ORIC vs PRTA Comparison Chart
Loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ORIC vs. PRTA commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORIC is a Buy and PRTA is a Sell.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (ORIC: $10.28 vs. PRTA: $17.23)
Brand notoriety: ORIC and PRTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORIC: 114% vs. PRTA: 73%
Market capitalization -- ORIC: $725.18M vs. PRTA: $926.64M
ORIC [@Biotechnology] is valued at $725.18M. PRTA’s [@Biotechnology] market capitalization is $926.64M. The market cap for tickers in the [@Biotechnology] industry ranges from $473.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORIC’s FA Score shows that 1 FA rating(s) are green whilePRTA’s FA Score has 0 green FA rating(s).

  • ORIC’s FA Score: 1 green, 4 red.
  • PRTA’s FA Score: 0 green, 5 red.
According to our system of comparison, ORIC is a better buy in the long-term than PRTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORIC’s TA Score shows that 6 TA indicator(s) are bullish while PRTA’s TA Score has 3 bullish TA indicator(s).

  • ORIC’s TA Score: 6 bullish, 4 bearish.
  • PRTA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ORIC is a better buy in the short-term than PRTA.

Price Growth

ORIC (@Biotechnology) experienced а -0.19% price change this week, while PRTA (@Biotechnology) price change was -6.10% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.97%. For the same industry, the average monthly price growth was +5.49%, and the average quarterly price growth was +6.49%.

Reported Earning Dates

ORIC is expected to report earnings on Mar 25, 2025.

PRTA is expected to report earnings on Feb 13, 2025.

Industries' Descriptions

@Biotechnology (-1.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRTA($927M) has a higher market cap than ORIC($725M). ORIC YTD gains are higher at: 11.739 vs. PRTA (-52.587). PRTA has higher annual earnings (EBITDA): -90.41M vs. ORIC (-124.06M). PRTA has more cash in the bank: 564M vs. ORIC (286M). ORIC has less debt than PRTA: ORIC (2.77M) vs PRTA (12.1M). PRTA has higher revenues than ORIC: PRTA (217M) vs ORIC (0).
ORICPRTAORIC / PRTA
Capitalization725M927M78%
EBITDA-124.06M-90.41M137%
Gain YTD11.739-52.587-22%
P/E RatioN/AN/A-
Revenue0217M-
Total Cash286M564M51%
Total Debt2.77M12.1M23%
FUNDAMENTALS RATINGS
PRTA: Fundamental Ratings
PRTA
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
PROFIT vs RISK RATING
1..100
84
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORICPRTA
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
74%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
Momentum
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
89%
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
87%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
76%
Declines
ODDS (%)
Bearish Trend 21 days ago
86%
Bearish Trend 1 day ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
73%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
85%
View a ticker or compare two or three
Ad is loading...
ORIC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
PRTA
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVKIX21.940.06
+0.27%
VY® Invesco Comstock I
BREIX41.86-0.01
-0.02%
Baron Real Estate Institutional
QQMNX21.23-0.01
-0.05%
Federated Hermes MDT Market Neutral IS
FSBDX19.51-0.07
-0.36%
Fidelity Series Blue Chip Growth
RYCHX161.64-1.06
-0.65%
Rydex Technology C

ORIC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with DAWN. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
+0.19%
DAWN - ORIC
41%
Loosely correlated
-5.05%
KYMR - ORIC
40%
Loosely correlated
-2.74%
SVRA - ORIC
40%
Loosely correlated
-15.14%
ACLX - ORIC
40%
Loosely correlated
-0.34%
IMNM - ORIC
39%
Loosely correlated
-7.21%
More

PRTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRTA has been loosely correlated with PEPG. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if PRTA jumps, then PEPG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRTA
1D Price
Change %
PRTA100%
-0.75%
PEPG - PRTA
53%
Loosely correlated
+0.88%
BEAM - PRTA
51%
Loosely correlated
-1.57%
DNLI - PRTA
50%
Loosely correlated
-0.84%
RGNX - PRTA
49%
Loosely correlated
+1.81%
NAUT - PRTA
48%
Loosely correlated
-0.80%
More